New study finds that people who felt they were coerced into being hospitalized were more likely to attempt suicide later.
New research counters the long-held assumption that a longer duration of untreated psychosis is associated with worse outcomes.
A new meta-analysis finds that the large antidepressant effects of exercise may have been underestimated in previous reviews. This latest report, published this month...
MIA’s Ayurdhi Dhar interviews Joseph Gone about how a history of dispossession, conquest, and colonization shapes mental health outcomes in Native American communities.
Lithium appears to reduce libido and sexual function, and more research into the problem is needed.
In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.
A new meta-analysis finds that DBT reduces self-harm, suicide attempts, and reduces the frequency of psychiatric crisis service utilization.
MIA’s Justin Karter interviews critical psychiatrist and philosopher Pat Bracken about the necessity of challenging received wisdom.
Ayahuasca found to be effective in treating moderate to severe depression in low-income population.
Researchers confirm that the suicide warning for antidepressants is justified by the evidence and that claims that the warning is harmful lack support.
In-depth interviews find that those who screened positive for depression did not explain their experience in terms of diagnostic symptoms.
A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.
The latest issue of the journal Behavioral and Brain Sciences features several prominent researchers arguing that mental health concerns are not “brain disorders.”
A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.
A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.
Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...
Researchers found acupuncture effective in the treatment of chronic pain and depression
A new study, published in Psychotherapy Research, explores how having a career in psychotherapy affects therapists’ personal lives.
CBT forwards a hyper-rational perspective of human suffering that complements a managerialist culture of efficiency and institutionalization in the Western world.
A new survey exploring antipsychotic user experience finds that more than half of the participants report only negative experiences.
About 9% fewer Americans are using prescription opioids than were five years ago, but those people are taking more of the drugs for longer periods of time, according to a study by pharmacy benefits manager Express Scripts reported in FiercePharma. And nearly one-third are being put in serious risk of overdose death by taking the opioids alongside prescriptions for benzodiazepine sedatives, stated the New York Times.
Training for conceptual competence in psychiatry provides a new way forward to address theoretical and philosophical issues in mental health research and practice.
New study finds that Medicaid enrolled youth were 14 times more likely to be on an antidepressant in 2014 than in 1987.
A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.
MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.